Nitisinone
( DrugBank: Nitisinone / KEGG DRUG: Nitisinone )
3 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
6 | Parkinson disease | 2 |
164 | Oculocutaneous albinism | 1 |
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
241 | Hypertyrosinemia type I | 13 |
6. Parkinson disease
Clinical trials : 2,586 / Drugs : 1,871 - (DrugBank : 354) / Drug target genes : 188 - Drug target pathways : 205
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
164. Oculocutaneous albinism
Clinical trials : 16 / Drugs : 44 - (DrugBank : 27) / Drug target genes : 30 - Drug target pathways : 137
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
241. Hypertyrosinemia type I
Clinical trials : 15 / Drugs : 6 - (DrugBank : 1) / Drug target gene : 1 - Drug target pathways : 3
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|